Enquiry/Quote
No Image Available

Tofacitinib Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 5 mg

Reference Brands:

Category: Arthritis

It is used to treat Rheumatoid arthritis, Psoriatic arthritis, ulcerative colitis, polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis. Rheumatoid arthritis is a form of arthritis that causes pain, swelling, stiffness, and loss of function in the joints.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

πŸ“˜ Sourcing Guide

Product Description: Psoriatic arthritis is a form of arthritis that affects some people having psoriasis – a condition in which itchy, scaly red patches appear on the scalp and skin. Juvenile psoriatic arthritis is psoriatic arthritis affecting children. Ulcerative colitis is a disease in which inflammation and ulcers are developed in the digestive tract, primarily in the large intestine and rectum. Polyarticular juvenile idiopathic arthritis is childhood arthritis that causes swelling of joints and pain. This medication is not advisable for lactose intolerant patients as this medicine contains lactose.

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Related Products

Pegloticase Injecatble

Strength:
8 mg/1.2 mL vial

Form: Injectable (IV solution)

Reference Brands: Krystexxa (US)

View Details
Colchicine Tablest

Strength:
0.6 mg

Form: Tablet

Reference Brands: Colcrys(US)

View Details
Febuxostat Tablets

Strength:
40 mg, 80 mg

Form: Oral Tablets

Reference Brands: Uloric(EU & US)

View Details
Allopurinol Tablets

Strength:
100 mg, 300 mg

Form: Oral Tablets

Reference Brands: Aloprim(US & EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.